# Measuring Parkinson's Disease Progression

> **NCT03205956** · PHASE1 · COMPLETED · sponsor: **Kevin J. Black, MD** · enrollment: 31 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Levodopa

## Key facts

- **NCT ID:** NCT03205956
- **Lead sponsor:** Kevin J. Black, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-19
- **Primary completion:** 2019-10-18
- **Final completion:** 2019-10-19
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2022-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03205956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03205956, "Measuring Parkinson's Disease Progression". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03205956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*